1. A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma. (April 2021) Authors: Yang, Eddy S.; Deutsch, Eric; Mehmet, Altan; Fayette, Jerome; TAO, Yungan; Nabell, Lisle; Spencer, Sharon A.; Wang, Xuejing A.; Spoljoric, Elizabeth A.; Zhang, Wei; Hynes, Scott M.; Decker, Rodney L.; Lin, Aimee K. Bence; William, William N. Journal: Radiotherapy and oncology Issue: Volume 157(2021) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. (4th June 2018) Authors: Gillison, Maura L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; T... Journal: Oncologist Issue: Volume 23:Number 9(2018) Page Start: 1079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical and histological characteristics, and management of melanoma in French Guiana, 2007–2018. (7th June 2020) Authors: Broly, Marine; Drak Alsibai, Kinan; Cenciu, Beatrice; Guevara, Hemerson; Fayette, Jerome; Neidhardt, Eve‐Marie; Demar, Magalie; Couppie, Pierre; Blaizot, Romain Journal: International journal of dermatology Issue: Volume 59:Number 8(2020) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN. Issue 6 (1st December 2020) Authors: Morfouace, Marie; Stevovic, Aleksandra; Vinches, Marie; Golfinopoulos, Vassilis; Jin, Dexter X.; Holmes, Oliver; Erlich, Rachel; Fayette, Jerome; Croce, Sabrina; Ray-Coquard, Isabelle; Girard, Nicolas; Blay, Jean-Yves Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN. Issue 6 (1st December 2020) Authors: Morfouace, Marie; Stevovic, Aleksandra; Vinches, Marie; Golfinopoulos, Vassilis; Jin, Dexter X.; Holmes, Oliver; Erlich, Rachel; Fayette, Jerome; Croce, Sabrina; Ray-Coquard, Isabelle; Girard, Nicolas; Blay, Jean-Yves Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN. Issue 6 (1st December 2020) Authors: Morfouace, Marie; Stevovic, Aleksandra; Vinches, Marie; Golfinopoulos, Vassilis; Jin, Dexter X.; Holmes, Oliver; Erlich, Rachel; Fayette, Jerome; Croce, Sabrina; Ray-Coquard, Isabelle; Girard, Nicolas; Blay, Jean-Yves Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141. (15th February 2022) Authors: Gillison, Maura L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara... Journal: Oncologist Issue: Volume 27:Number 2(2022) Page Start: e194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651. Issue 12 (20th April 2023) Authors: Haddad, Robert I.; Harrington, Kevin; Tahara, Makoto; Ferris, Robert L.; Gillison, Maura; Fayette, Jerome; Daste, Amaury; Koralewski, Piotr; Zurawski, Bogdan; Taberna, Miren; Saba, Nabil F.; Mak, Milena; Kawecki, Andrzej; Girotto, Gustavo; Alvarez Avitia, Miguel Angel; Even, Caroline; Toledo, Joa... Journal: Journal of clinical oncology Issue: Volume 41:Issue 12(2023) Page Start: 2166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial. Issue 18 (27th June 2019) Authors: Haddad, Robert; Concha‐Benavente, Fernando; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Kasper, Stefan; Vokes, Everett E.; Worden, Francis; Saba, Nabil F.; Tahara, Makoto; Jayaprakash, Vijayvel; Lynch, Mark; Li, Li; Gillison, Maura L.; Harrington, Ke... Journal: Cancer Issue: Volume 125:Issue 18(2019) Page Start: 3208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age. (September 2019) Authors: Saba, Nabil F.; Blumenschein, George; Guigay, Joel; Licitra, Lisa; Fayette, Jerome; Harrington, Kevin J.; Kiyota, Naomi; Gillison, Maura L.; Ferris, Robert L.; Jayaprakash, Vijayvel; Li, Li; Brossart, Peter Journal: Oral oncology Issue: Volume 96(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗